Company profile: Cypher Genomics
1.1 - Company Overview
Company description
- Provider of automated human genome interpretation software for next-generation sequencing, supporting diagnostics development and biomarker analysis for clinical labs, pharmaceutical companies, and population genomics efforts; offers the Mantis Genomic Coral Biomarker Array Chip, qPCR Assay, and miscellaneous diagnostic ELISA kits. Platform allows clinical labs to tune sensitivity and specificity.
Products and services
- Mantis Genomic Coral Biomarker Array Chip: A genomic array chip that identifies and analyzes biomarkers in genomic data, supporting diagnostics development and biomarker research
- Miscellaneous Diagnostic ELISA Kits: Diagnostic enzyme-linked immunosorbent assay kits that detect various biomarkers and proteins in biological samples, supporting biomarker detection workflows
- QPCR Assay: A quantitative polymerase chain reaction assay that measures DNA or RNA levels in samples for precise nucleic acid quantification
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cypher Genomics
Unlearn
HQ: United States
Website
- Description: Provider of AI, digital twin, and statistical methods to enable smaller, more efficient clinical trials, offering TwinRCTs (RCTs enhanced with AI-generated digital twins), Digital Twin Generators to predict individual health outcomes over time, regulatory services to navigate and meet FDA and EMA guidelines, and PROCOVA using prognostic scores from digital twins to enhance statistical power.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Unlearn company profile →
Eikon Therapeutics
HQ: United States
Website
- Description: Provider of live-cell single-molecule tracking and super-resolution microscopy technologies for drug discovery, offering proprietary hardware, AI and machine learning integration, and custom reagents and automation to enable high-throughput analysis of protein dynamics and interactions, alongside a therapeutic pipeline in oncology, immunology, and neuroscience.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eikon Therapeutics company profile →
eClinical Solutions
HQ: United States
Website
- Description: Provider of a data intelligence hub that transforms clinical data integration, aggregation, and analytics, leveraging clinical trial expertise and platforms including Rave Clinical Cloud and the elluminate Clinical Data Cloud; offerings include Mapper, Data Central, Clinical Analytics, Risk-Based Quality Management, and eIQ Review to accelerate clinical development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full eClinical Solutions company profile →
Bio Balance
HQ: United States
Website
- Description: Provider of studies of biomedical problems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bio Balance company profile →
Citeline
HQ: United States
Website
- Description: Provider of clinical trial intelligence solutions for real-time R&D in the pharmaceutical industry worldwide, including Trialtrove for global trial tracking, Trialpredict for timing forecasts, Pharmaprojects for drug profiles, Sitetrove for site and investigator data, TrialScope Disclose and TrialScope Intelligence for disclosure compliance, Citeline Connect for patient recruitment, and Disclosure Services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Citeline company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cypher Genomics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cypher Genomics
2.2 - Growth funds investing in similar companies to Cypher Genomics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cypher Genomics
4.2 - Public trading comparable groups for Cypher Genomics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →